4
Changes in Ownership
ENDONOVO THERAPEUTICS, INC. Filed Acc 0001645470-19-000028
CEO bought 179,000 shares at an average $0.01 ($1,974)
From the SEC's structured data for this filing
Trades in this filing
Collier Alan Brian · CEO
Table I: Non-derivative
30 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2019-05-01 | Purchase : show line 1 in the form | +2,000 | $0.01 | $24 | 21,160,123 | D |
| 2019-05-01 | Purchase : show line 2 in the form | +2,000 | $0.01 | $23 | 21,162,123 | D |
| 2019-05-01 | Purchase : show line 3 in the form | +5,000 | $0.01 | $57 | 21,167,123 | D |
| 2019-05-01 | Purchase : show line 4 in the form | +5,000 | $0.01 | $59 | 21,172,123 | D |
| 2019-05-01 | Purchase : show line 5 in the form | +2,000 | $0.01 | $24 | 21,174,123 | D |
| 2019-05-01 | Purchase : show line 6 in the form | +2,000 | $0.01 | $24 | 21,176,123 | D |
| 2019-05-01 | Purchase : show line 7 in the form | +2,000 | $0.01 | $24 | 21,178,123 | D |
| 2019-05-01 | Purchase : show line 8 in the form | +2,000 | $0.01 | $24 | 21,180,123 | D |
| Open-market purchases · 179,000 sh · avg $0.01 · $1,974 | ||||||
Loading xslF345X03/primary_doc.xml…